Search - tctmd.com

Displaying 181 - 200 of 321

Sort: Relevancy | Date

News Industry News

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

October 29, 2013

News Industry News

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

October 29, 2013

News Conference News TCT 2013

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

October 28, 2013

News Conference News TCT 2013

Preliminary Data Show Potential of Renal Denervation in Several Settings

October 28, 2013

News Industry News

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

October 28, 2013

News Conference News TCT 2013

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

October 28, 2013

News Daily News

Fewer Adverse Events with Radial vs. Femoral PCI in High-Risk IABP Patients

Jason Kahn

October 25, 2013

News Industry News

FDA Advisory Panel Recommends Expanded Indication for Medtronic CRT Devices in Patients with AV Block and Reduced Heart Function

October 08, 2013

News Daily News

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

L.A. McKeown

September 27, 2013

News Daily News

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

September 27, 2013

News Daily News

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

Yael L. Maxwell

September 27, 2013

News Daily News

US Registry Study Explores Factors Tied to ‘Inappropriate’ PCI

Caitlin E. Cox

September 20, 2013

News Daily News

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

September 20, 2013

News Daily News

Meta-analysis: Cell Therapy Improves LV Function in Majority of STEMI Patients

Jason Kahn

September 20, 2013

News Daily News

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

September 13, 2013

News Conference News ESC 2013

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

Caitlin E. Cox

September 04, 2013

News Conference News ESC 2013

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Caitlin E. Cox

September 04, 2013

News Industry News

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

September 03, 2013

News Industry News

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

September 02, 2013

News Daily News

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

July 19, 2013

Advertisement

New Data from St. Jude Medical Study of EnligHTN Renal Denervation System Presented Today at Scientific Symposium

New Data Continue To Show Significant and Sustained Blood Pressure Reduction

Renal Denervation for Moderate Treatment-Resistant Hypertension Explored

Preliminary Data Show Potential of Renal Denervation in Several Settings

NEW DATA CONTINUE TO SHOW SIGNIFICANT AND SUSTAINED BLOOD PRESSURE REDUCTION WITH BOSTON SCIENTIFIC VESSIX™ RENAL DENERVATION SYSTEM

Measuring Response to Renal Denervation Depends on BP Decline, Clinical Relevance

Fewer Adverse Events with Radial vs. Femoral PCI in High-Risk IABP Patients

FDA Advisory Panel Recommends Expanded Indication for Medtronic CRT Devices in Patients with AV Block and Reduced Heart Function

Distal Protection Adds Early Boost to Thrombectomy in STEMI, but No Lasting Benefit

CADUCEUS: Autologous Stem Cells Safely Reverse Some MI Damage

Baseline White Blood Cell Count Predicts Infarct Size in Anterior STEMI

US Registry Study Explores Factors Tied to ‘Inappropriate’ PCI

NCDR Registries Give Nationwide Assessment of Cardiovascular Care

Meta-analysis: Cell Therapy Improves LV Function in Majority of STEMI Patients

Baroreflex Sensitivity May Help Target Likely Responders to Renal Denervation

Symplicity Studies Support Safety, Efficacy of Percutaneous Renal Denervation

AQUARIUS: Aliskiren Fails Primary Endpoint But Surprises with MACE Reduction

Medtronic Presents Final Three-Year Data From Symplicity HTN-1 Showing Significant and Sustained Drops in Blood Pressure After Treatment with the Symplicity(TM) Renal Denervation System

Medtronic Reports Strong Safety and Sustained Clinical Efficacy Results of the Symplicity(TM) Renal Denervation System from the Global SYMPLICITY Registry

Renal Denervation Safe, Effective for Moderate Resistant Hypertension in Pilot Study

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content